US Patent Issued to Rubin Arkady on Aug. 19 for "Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen" (New Jersey Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,476, issued on Aug. 19, was assigned to Rubin Arkady (Flemington, N.J.).

"Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen" was invented by Arkady Rubin (Flemington, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for contraception includes administering to a female daily, in a triphasic dosing regimen during a time period of 21 successive days, an oral combination drug formulation of norethindrone acetate and ethinyl estradiol (EE), wherein doses in the second, third and fourth phases of the regimen increase by a predefined dose increment as compared to the corresponding doses administer...